The effect of Misoprostol, a prostaglandin E1 analog, on apoptosis in ischemia-reperfusion-induced intestinal injury

Acta Histochemica

Volumn 109, Issue 4, 2007, Pages 322-329

  Topcu, Ismet ^a   Vatansever, Seda ^a   Var, Ahmet ^a   Cavus, Zuhal ^a   Cilaker, Serap ^a   Sakarya, Melek ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Ileum; Ischemia reperfusion; Misoprostol; Prostaglandin E1; Rats

Indexed keywords

ALDEHYDES; CELL DEATH; ENZYME KINETICS; HORMONES; IMMUNOLOGY; RATS;

ILEUM; IMMUNOHISTOCHEMICAL ANALYSIS; MALONDIALDEHYDE (MDA); MISOPROSTOL; PROSTAGLANDIN (PG);

FATTY ACIDS;

MISOPROSTOL; PROSTAGLANDIN E1; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; HISTOLOGY; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE INJURY; ISCHEMIA; MALE; NICK END LABELING; NONHUMAN; PATHOPHYSIOLOGY; RAT; REPERFUSION;

ANIMALIA; RATTUS;

EID: 34250713397     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2006.10.007     Document Type: Article

References (37)

1. Alexander J.W., Gianotti L., Pyles T., Carey M.A., and Babcock G.F. Distribution and survival of Escherichia coli translocating from the intestine after thermal injury. Ann Surg 213 (1991) 558-566
2. Banda M.A., and Granger D.N. Mechanism and protection from ischemic intestinal injury. Transplant Proc 28 (1996) 2595-2597
3. Barriere S.L., and Lowry S.F. An overview of mortality risk prediction in sepsis. Crit Care Med 23 (1995) 376-393
4. Baue A.E., Durham R., and Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle?. Shock 10 (1998) 79-89
5. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., and Lipton S.A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92 (1995) 7162-7166
6. Carrico C.J., Meakins J.L., Marshall J.C., Fry D., and Maier R.V. Multiple-organ-failure syndrome. Arch Surg 121 (1986) 196-208
7. Dajani E.Z., and Agrawal N.M. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs. Dig Dis 13 (1995) 48-61
8. Davies N.M., Longstreth J., and Jamali F. Misoprostol therapeutics revisited. Pharmacotherapy 21 (2001) 60-73
9. Flemstrom G., and Garner A. Gastroduodenal HCO30 transport: characteristics and proposed role in acidity regulation and mucosal protection. Am J Physiol 242 (1982) G183-G193
10. Graham D.Y., Agrawal N.M., and Roth S.H. Prevention of NSAID induced gastric ulcer with misoprostol: multicentre double-blind, placebo controlled trial. Lancet 2 (1988) 1277-1280
11. Hashimoto S., Ochs R.L., Rosen F., Quach J., McCabe G., Solan J., et al. Chondrocyte derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 95 (1998) 3094-3099
12. Ikeda H., Suzuki Y., Suzuki M., Koike M., Tamura J., Tong J., et al. Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut 42 (1998) 530-537
13. Kalff J.C., Schraut W.H., Billiar T.R., Simmons R.L., and Bauer A.J. Role of inducible nitric oxide synthase in postoperative intestinal smooth muscle dysfunction in rodents. Gastroenterology 118 (2000) 316-327
14. Livingston D.H., Mosenthal A.C., and Deitch E.A. Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview. New Horiz 3 (1995) 257-266
15. Lowenstein C.J., and Snyder S.H. Nitric oxide, a novel biologic messenger. Cell 70 (1992) 705-707
16. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
17. McCafferty D.M., Mudgett J.S., Swain M.G., and Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 112 (1997) 1022-1027
18. Miller T.A. Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. Am J Physiol 245 (1983) G601-G623
19. Nathan C. Inducible nitric oxide synthase: what differences does it make?. J Clin Invest 100 (1997) 2417-2423
20. Noda T., Iwakiri R., Fujimoto K., Matsuo S., and Aw T.Y. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. Am J Physiol 274 (1998) G270-G276
21. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351-358
22. Paglia D.E., and Walentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70 (1967) 158-169
23. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
24. Parks D.A., and Granger D.N. Ischemia induced vascular changes: role of xanthine oxidase and hydroxyl radicals. Am J Physiol 245 (1983) 285-289
25. Potten C.L., and Hanson P.J. Exogenous nitric oxide inhibits apoptosis in guinea pig gastric mucous cells. Gut 46 (2000) 156-162
26. Riedemann N.C., Guo R.F., and Ward P.A. The enigma of sepsis. Clin Invest 112 (2003) 460-467
27. Sato N., Kawano S., Kamada T., and Takeda M. Hemodynamic of the gastric mucosa and gastric ulceration in rats and in patients with gastric ulcer. Dig Dis Sci 3 (1986) 35-41
28. Schoenberg M.H., and Beger H.G. Reperfusion injury after intestinal ischemia. Crit Care Med 21 (1993) 1376-1386
29. Sellers L.A., Carroll N.J., and Allen A. Misoprostol-induced increases in adherent gastric mucus thickness and luminal mucus output. Dig Dis Sci 31 (1986) S91-S95
30. Sencan A., Yilmaz O., Ozer E., Gunsar C., Genc K., Ulukus C., et al. Does sucralfate prevent apoptosis occurring in the ischemia/reperfusion-induced intestinal injury?. Eur J Pediatr Surg 13 (2003) 231-235
31. Sener G., Akgun U., Satiroglu H., Topaloglu U., and Keyer-Uysal M. The effect of pentoxifylline on intestinal ischemia/reperfusion injury. Fundam Clin Pharmacol 15 1 (2001) 19-22
32. Shah K.A., Shurey S., and Green C.J. Characterization of apoptosis in intestinal ischemia-reperfusion injury; a light and electron microscopic study. Int J Exp Pathol 78 (1997) 355-363
33. Smedfors B., and Johansson C. Stimulation of duodenal bicarbonate secretion by misoprostol. Dig Dis Sci 3 (1986) S96-S100
34. Sun Y., Oberley L.W., and Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
35. Takeuchi K., Yagi K., Kato S., and Ukawa H. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology 113 (1997) 1553-1559
36. Van Ye T.M., Roza A.M., Pieper G.M., Henderson Jr. J., Johnson C.P., and Adams M.B. Inhibition of intestinal lipid peroxidation does not minimize morphologic damage. J Surg Res 55 5 (1993) 553-558
37. Wu B., Iwakiri R., Tsunada S., Utsumi H., Kojima M., Fujise T., et al. iNOS enhances rat intestinal apoptosis after ischemia-reperfusion. Free Radic Biol Med 33 (2002) 649-658